Hemostasis, LLC is a healthcare and manufacturing startup founded in 2006. With the slogan "Innovative Products that support Hospital and Surgical Care Around the Globe," the company designs and manufactures advanced technology for hemostasis, specifically advanced blood clotting technology.
Their flagship products, NexStat Topical Hemostat Powder and NexFoam, address the need for effective hemostatic solutions. NexStat is designed for use as a topical dressing for the temporary treatment of bleeding wounds such as surgical wounds, cuts, and lacerations. On the other hand, NexFoam is a versatile sponge that can be used as a spacer, stent, and hemostat. Both products are biocompatible and offer ease of use as they require no special storage conditions and dissolve naturally or can be removed with gentle irrigation.
Hemostasis, LLC operates within the Health Care, Manufacturing, and Medical Devices industries. As of now, there is no publicly available information about the company's headquarters or any recent investments and investors.
The company's focus on innovative healthcare solutions positions them at the forefront of addressing critical needs in surgical and hospital care, making it an interesting prospect for potential investors in the healthcare and medical devices sectors.
-logo.jpg "Arch Therapeutics, Inc (OTCQB:ARTH)"){kind=logo}
